Literature DB >> 33573224

Metabolic Control of m6A RNA Modification.

Joohwan Kim1, Gina Lee2.   

Abstract

Nutrients and metabolic pathways regulate cell growth and cell fate decisions via epigenetic modification of DNA and histones. Another key genetic material, RNA, also contains diverse chemical modifications. Among these, N6-methyladenosine (m6A) is the most prevalent and evolutionarily conserved RNA modification. It functions in various aspects of developmental and disease states, by controlling RNA metabolism, such as stability and translation. Similar to other epigenetic processes, m6A modification is regulated by specific enzymes, including writers (methyltransferases), erasers (demethylases), and readers (m6A-binding proteins). As this is a reversible enzymatic process, metabolites can directly influence the flux of this reaction by serving as substrates and/or allosteric regulators. In this review, we will discuss recent understanding of the regulation of m6A RNA modification by metabolites, nutrients, and cellular metabolic pathways.

Entities:  

Keywords:  N6-methyladenosine; RNA chemical modification; RNA epitranscriptome; RNA methylation; m6A; metabolic pathways; metabolites; nutrient signaling

Year:  2021        PMID: 33573224      PMCID: PMC7911930          DOI: 10.3390/metabo11020080

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  105 in total

1.  Direct activation of RNA polymerase III transcription by c-Myc.

Authors:  Natividad Gomez-Roman; Carla Grandori; Robert N Eisenman; Robert J White
Journal:  Nature       Date:  2003-01-16       Impact factor: 49.962

2.  Widespread reorganization of metabolic enzymes into reversible assemblies upon nutrient starvation.

Authors:  Rammohan Narayanaswamy; Matthew Levy; Mark Tsechansky; Gwendolyn M Stovall; Jeremy D O'Connell; Jennifer Mirrielees; Andrew D Ellington; Edward M Marcotte
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-05       Impact factor: 11.205

3.  Target identification using drug affinity responsive target stability (DARTS).

Authors:  Brett Lomenick; Rui Hao; Nao Jonai; Randall M Chin; Mariam Aghajan; Sarah Warburton; Jianing Wang; Raymond P Wu; Fernando Gomez; Joseph A Loo; James A Wohlschlegel; Thomas M Vondriska; Jerry Pelletier; Harvey R Herschman; Jon Clardy; Catherine F Clarke; Jing Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

Review 4.  Gene expression regulation mediated through reversible m⁶A RNA methylation.

Authors:  Ye Fu; Dan Dominissini; Gideon Rechavi; Chuan He
Journal:  Nat Rev Genet       Date:  2014-03-25       Impact factor: 53.242

5.  Chemical inhibitors make their RNA epigenetic mark.

Authors:  Megan Cully
Journal:  Nat Rev Drug Discov       Date:  2019-11       Impact factor: 84.694

Review 6.  The Emerging Hallmarks of Cancer Metabolism.

Authors:  Natalya N Pavlova; Craig B Thompson
Journal:  Cell Metab       Date:  2016-01-12       Impact factor: 27.287

Review 7.  m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.

Authors:  Huilin Huang; Hengyou Weng; Jianjun Chen
Journal:  Cancer Cell       Date:  2020-03-16       Impact factor: 31.743

8.  Structural insights into the RNA methyltransferase domain of METTL16.

Authors:  Agnieszka Ruszkowska; Milosz Ruszkowski; Zbigniew Dauter; Jessica A Brown
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

9.  Ythdf2-mediated m6A mRNA clearance modulates neural development in mice.

Authors:  Miaomiao Li; Xu Zhao; Wei Wang; Hailing Shi; Qingfei Pan; Zhike Lu; Sonia Peña Perez; Rajikala Suganthan; Chuan He; Magnar Bjørås; Arne Klungland
Journal:  Genome Biol       Date:  2018-05-31       Impact factor: 13.583

10.  m6A mRNA Methylation Regulates Human β-Cell Biology in Physiological States and in Type 2 Diabetes.

Authors:  Dario F De Jesus; Zijie Zhang; Sevim Kahraman; Natalie K Brown; Mengjie Chen; Jiang Hu; Manoj K Gupta; Chuan He; Rohit N Kulkarni
Journal:  Nat Metab       Date:  2019-07-29
View more
  7 in total

Review 1.  The hallmarks of cancer metabolism: Still emerging.

Authors:  Natalya N Pavlova; Jiajun Zhu; Craig B Thompson
Journal:  Cell Metab       Date:  2022-02-04       Impact factor: 27.287

Review 2.  m6A in the Signal Transduction Network.

Authors:  Ki-Hong Jang; Chloe R Heras; Gina Lee
Journal:  Mol Cells       Date:  2022-06-24       Impact factor: 4.250

3.  Lipid metabolism and m6A RNA methylation are altered in lambs supplemented rumen-protected methionine and lysine in a low-protein diet.

Authors:  Kefyalew Gebeyew; Chao Yang; Hui Mi; Yan Cheng; Tianxi Zhang; Fan Hu; Qiongxian Yan; Zhixiong He; Shaoxun Tang; Zhiliang Tan
Journal:  J Anim Sci Biotechnol       Date:  2022-07-13

4.  ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators.

Authors:  Zhonglin Cai; Huan Xu; Gang Bai; Hanjing Hu; Di Wang; Hongjun Li; Zhong Wang
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

5.  Multivariate Analysis of RNA Chemistry Marks Uncovers Epitranscriptomics-Based Biomarker Signature for Adult Diffuse Glioma Diagnostics.

Authors:  S Relier; A Amalric; A Attina; I B Koumare; V Rigau; F Burel Vandenbos; D Fontaine; M Baroncini; J P Hugnot; H Duffau; L Bauchet; C Hirtz; E Rivals; A David
Journal:  Anal Chem       Date:  2022-08-23       Impact factor: 8.008

6.  Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA.

Authors:  WeiChao Hao; MeiJuan Dian; Ying Zhou; QiuLing Zhong; WenQian Pang; ZiJian Li; YaYan Zhao; JiaCheng Ma; XiaoLin Lin; RenRu Luo; YongLong Li; JunShuang Jia; HongFen Shen; ShiHao Huang; GuanQi Dai; JiaHong Wang; Yan Sun; Dong Xiao
Journal:  Nat Commun       Date:  2022-10-04       Impact factor: 17.694

7.  YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy.

Authors:  Hongfei Xu; Zhen Wang; Miao Chen; Wenting Zhao; Tingting Tao; Liang Ma; Yiming Ni; Weidong Li
Journal:  Cell Biosci       Date:  2021-07-15       Impact factor: 7.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.